Working to Fight AMR

Antimicrobial resistance or #AMR is a public health crisis. Globally, antibiotic-resistant infections contributed to nearly 5 million deaths in 2021. By 2050, AMR will contribute to nearly 170 million deaths. Learn more about the fight to stop #superbugs: buff.ly/4huPc8k

In @wef, experts warn that AMR could undermine modern medicine far beyond infectious disease care. As drug-resistant infections rise, experts say cancer treatments, transplants, and immune therapies may become increasingly difficult to deliver safely. weforum.org/stories/2026/0…

In @SciTechDaily1, researchers have developed a low-cost sulfur-based material that can kill drug-resistant bacteria and fungi without harming human cells, pointing to a promising new approach to combating antimicrobial resistance. Learn more: scitechdaily.com/scientists-dis…

A new study finds one STI prevention strategy may be losing effectiveness against gonorrhea as resistance rises. Researchers say the findings underscore the ongoing challenge of fighting against antimicrobial resistance. More in @CIDRAP: cidrap.umn.edu/antimicrobial-…

In @ICT_Magazine, Emily Wheeler, vice president of infectious disease policy at @IAmBiotech, discusses how policies like the PASTEUR Act could help stabilize the antibiotic pipeline as the health care system faces threats from drug-resistant infections. infectioncontroltoday.com/view/pasteur-a…

In @ContagionLive, Marianna Castanheira of JMI Laboratories explains how extremely hard-to-treat Gram-negative bacteria are becoming increasingly resistant to some of medicine's strongest antibiotics, underscoring the need for new treatments. contagionlive.com/view/rising-th…

Experts warn the threat of drug-resistant fungi has been quietly building for years. As infections become harder to treat and antifungal options remain limited, the world urgently needs better antifungals, diagnostics, and surveillance. More in @Inc: inc.com/lucia-auerbach…

In @statesman, Henry Skinner, CEO of @AMRActionFund, warns rising cases of drug-resistant fungi like Candida auris expose major gaps in antifungal development and surveillance, and argues policies like the PASTEUR Act are needed to spur progress. statesman.com/opinion/column…

A @jac_amr review finds better-resourced antimicrobial stewardship programs are linked to more targeted antibiotic use and lower costs, and experts say stronger staffing and support are key to managing use and slowing resistance. More in @CIDRAP cidrap.umn.edu/antimicrobial-…

In @WIRED, Ara Darzi, director of the Institute of Global Health Innovation at @imperialcollege, says AI could transform how we diagnose and treat drug-resistant infections, but without new incentives, groundbreaking discoveries may never reach patients. wired.com/story/wired-he…

In an op-ed in @thehill, Henry Skinner, CEO of @AMRActionFund, points to recent examples that the market for antimicrobial development is broken, and argues policies like the PASTEUR Act are needed to fix it. thehill.com/opinion/health…

A common skincare ingredient may double as a new weapon against superbugs. Researchers found madecassic acid can stop drug-resistant bacteria from growing by targeting a protein they rely on for survival. More in @ScienceDaily: sciencedaily.com/releases/2026/…

In @ContagionLive, @AMRActionFund CEO Henry Skinner warns antimicrobial resistance drives nearly 5 million deaths globally each year. He explains how policies like the PASTEUR Act can help revive the antibiotic pipeline. Watch: contagionlive.com/view/efforts-t…

Dr. Akhila Kosaraju of @PhareBio explains how AI is transforming antibiotic discovery -- predictive AI identifies promising compounds, while generative AI can design entirely new antibiotics from scratch. More in @ContagionLive: contagionlive.com/view/utilizing…

In @ContagionLive, Dr. Akhila Kosaraju of @PhareBio explains how AI-pharma partnerships are accelerating antibiotic development by designing drugs around clinical need and moving those candidates from discovery into trials more efficiently. Watch: contagionlive.com/view/pharma-an…

As part of its #FightOfOurLives campaign, @IAmBiotech shares the story of Katy Grainger’s life-threatening antibiotic-resistant infection. Policy can help U.S. biotech drive solutions to the most urgent health threats, including the growing crisis of AMR. fightofourlives.com/stories/katy/

In @ICT_Magazine, experts warn antimicrobial resistance is an underrecognized threat, putting healthcare workers at risk and undermining routine care -- all while first-line antibiotics become less effective. Read more: infectioncontroltoday.com/view/amr-healt…

As improved detection reveals more cases, Candida auris continues to spread due to its ability to persist in healthcare settings. Dr. Jatin Vyas of @Columbia explains in @ContagionLive: contagionlive.com/view/understan…

In @ContagionLive, Dr. Jatin Vyas of @Columbia highlights the growing threat of drug-resistant fungi like Candida auris and why the development of new antifungals remains a major challenge. Watch: contagionlive.com/view/multidrug…

Tuberculosis cases are rising in the U.S., raising renewed concerns about this otherwise curable infection. Experts warn that incomplete or delayed treatment can fuel drug-resistant TB, making early detection and proper care critical. More in @FoxNews: foxnews.com/health/cases-w…

Survival rates for the most challenging drug-resistant infections haven't improved, despite increased use of newer antibiotics to treat them. Experts say improved diagnostics that enable patients to be treated promptly could save lives. More in @CIDRAP: cidrap.umn.edu/antimicrobial-…